Prognostic value of electrocardiographic criteria for left ventricular hypertrophy

Bill P Hsieh1, Michael X Pham, Victor F Froelicher

  • 1Division of Cardiovascular Medicine, Stanford University School of Medicine, VA Palo Alto Health Care System, Palo Alto, CA 94304, USA.

American Heart Journal
|August 9, 2005
PubMed

Insights

Composite electrocardiogram (ECG) criteria for left ventricular hypertrophy (LVH) better predict cardiovascular (CV) mortality than voltage-only methods. Identifying high-risk patients with LVH using these ECG criteria can improve CV mortality outcomes.

Area of Science:

  • Cardiology
  • Medical Diagnostics
  • Public Health

Background:

  • Electrocardiogram (ECG) criteria for left ventricular hypertrophy (LVH) are numerous.
  • The comparative prognostic value of these ECG criteria for cardiovascular (CV) mortality is not well-established.

Purpose of the Study:

  • To compare the prognostic value of 17 common ECG criteria for LVH in predicting CV mortality.
  • To identify which ECG criteria are most effective in identifying patients at high risk for CV death.

Main Methods:

  • Analysis of ECGs from 46,950 consecutive male veterans with body mass index > 20.
  • Exclusion of patients with complicating illnesses or conduction abnormalities.
  • Cox regression models adjusted for age, heart rate, and body mass index to compare hazard ratios (HRs) for CV mortality.

Main Results:

  • During a mean follow-up of 7 years, 1254 (6%) of 19,434 patients died of CV causes.
  • Adjusted HRs for CV mortality varied from 1.4 to 3.7 across different ECG criteria.
  • Composite ECG criteria for LVH showed higher adjusted HRs than voltage-only criteria.
  • Left ventricular strain pattern and increased negative P-terminal force were the most predictive of CV mortality (HRs 3.9 and 3.5, respectively).

Conclusions:

  • Composite ECG criteria for LVH are more strongly predictive of CV mortality than voltage-only criteria.
  • Routine application of these composite ECG criteria can help identify high-risk individuals for timely intervention and improved outcomes.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and the T...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...